Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71205-569

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71205-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure diagram of tramadol hydrochloride showing its molecular arrangement with aromatic ring, hydroxyl group, and amine side chain.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph comparing tramadol concentration (ng/mL) over time (hours) for two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The graph shows plasma concentration levels fluctuating over a 24-hour period for both dosing regimens.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours and the y-axis represents M1 concentration, showing fluctuating concentration levels for both dosage forms throughout the time period.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

A line chart titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold (percent improvement from baseline). The graph compares Tramadol Hydrochloride extended-release tablets at 100 mg, 200 mg, 300 mg, and 400 mg doses with a placebo group, depicting patient response percentages on the vertical axis and response thresholds from 0 to 100 percent on the horizontal axis.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis,' showing percent of patients achieving various levels of response threshold. The x-axis represents response threshold as percent improvement from baseline, and the y-axis shows the percent of patients achieving response. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, with the tramadol group consistently showing higher response percentages across thresholds.*

FDA Label Image

71205-569-30 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 08)

Label for Tramadol HCl 300 mg extended-release tablets by Proficient Rx LP, NDC 71205-569-30, containing 30 tablets. Each tablet contains 300 mg tramadol hydrochloride USP. Manufactured by Lupin Limited, India. Label includes classification as a Schedule C-IV controlled substance, storage instructions, and batch/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.